A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Rezolute, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 315,845 shares of RZLT stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
315,845
Previous 315,845 -0.0%
Holding current value
$1.58 Million
Previous $1.36 Million 12.74%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.29 - $5.79 $723,285 - $1.83 Million
-315,845 Reduced 50.0%
315,845 $1.36 Million
Q2 2022

Aug 15, 2022

BUY
$2.6 - $3.85 $1.64 Million - $2.43 Million
631,690 New
631,690 $2.04 Million

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $194M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.